PL3421038T3 - Związek naftyrydyny, kompozycja farmaceutyczna i ich zastosowanie - Google Patents
Związek naftyrydyny, kompozycja farmaceutyczna i ich zastosowanieInfo
- Publication number
- PL3421038T3 PL3421038T3 PL16918185T PL16918185T PL3421038T3 PL 3421038 T3 PL3421038 T3 PL 3421038T3 PL 16918185 T PL16918185 T PL 16918185T PL 16918185 T PL16918185 T PL 16918185T PL 3421038 T3 PL3421038 T3 PL 3421038T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- naphthyridine compound
- naphthyridine
- compound
- pharmaceutical
- Prior art date
Links
- -1 Naphthyridine compound Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610880102.6A CN106749231B (zh) | 2016-10-09 | 2016-10-09 | 萘啶化合物和药物组合物及它们的应用 |
| EP16918185.6A EP3421038B1 (en) | 2016-10-09 | 2016-11-08 | Naphthyridine compound, pharmaceutical composition and use thereof |
| PCT/CN2016/105012 WO2018064852A1 (zh) | 2016-10-09 | 2016-11-08 | 萘啶化合物和药物组合物及它们的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3421038T3 true PL3421038T3 (pl) | 2020-06-29 |
Family
ID=58972188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16918185T PL3421038T3 (pl) | 2016-10-09 | 2016-11-08 | Związek naftyrydyny, kompozycja farmaceutyczna i ich zastosowanie |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9938274B1 (pl) |
| EP (1) | EP3421038B1 (pl) |
| JP (2) | JP6862563B2 (pl) |
| CN (1) | CN106749231B (pl) |
| AU (1) | AU2016425880B2 (pl) |
| ES (1) | ES2784525T3 (pl) |
| PL (1) | PL3421038T3 (pl) |
| PT (1) | PT3421038T (pl) |
| WO (1) | WO2018064852A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3371171B1 (en) | 2015-11-02 | 2023-10-25 | Blueprint Medicines Corporation | Inhibitors of ret |
| JP6997876B2 (ja) | 2018-01-18 | 2022-02-04 | アレイ バイオファーマ インコーポレイテッド | Ｒｅｔキナーゼ阻害剤としての置換ピラゾリル［４，３－ｃ］ピリジン化合物 |
| WO2019143977A1 (en) | 2018-01-18 | 2019-07-25 | Array Biopharma Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
| BR112020020273A2 (pt) | 2018-04-03 | 2021-04-06 | Blueprint Medicines Corporation | Inibidor de ret para uso no tratamento de câncer tendo uma alteração de ret |
| CN110862397A (zh) * | 2018-08-27 | 2020-03-06 | 北京赛特明强医药科技有限公司 | 二噁烷并喹唑啉与二噁烷并喹啉类化合物及其制备方法与应用 |
| EP4157829A1 (en) | 2020-05-29 | 2023-04-05 | Blueprint Medicines Corporation | Solid forms of pralsetinib |
| CN111961045A (zh) * | 2020-08-07 | 2020-11-20 | 南京纳丁菲医药科技有限公司 | 1,6-萘啶-4(1h)-酮化合物的合成方法 |
| CN113520999B (zh) * | 2021-07-30 | 2022-08-09 | 石家庄四药有限公司 | 含萘啶类化合物的口服液及其制备方法 |
| CN113633623A (zh) * | 2021-08-25 | 2021-11-12 | 石家庄四药有限公司 | 一种含萘啶类化合物的胶囊及其制备方法 |
| CN117486860A (zh) * | 2022-07-25 | 2024-02-02 | 上海博悦生物科技有限公司 | Axl&c-Met双重抑制剂、制备方法以及用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998013350A1 (en) | 1996-09-25 | 1998-04-02 | Zeneca Limited | Qinoline derivatives inhibiting the effect of growth factors such as vegf |
| WO2007095187A2 (en) * | 2006-02-13 | 2007-08-23 | Trustees Of Boston University | Compositions and methods for antibiotic potentiation and drug discovery |
| MY181439A (en) * | 2011-02-28 | 2020-12-22 | Sunshine Lake Pharma Co Ltd | Substituted quinoline compounds and methods of use |
| CN103183674B (zh) * | 2011-12-31 | 2017-09-12 | 江苏先声药业有限公司 | 一类稠杂环衍生物及其应用 |
-
2016
- 2016-10-09 CN CN201610880102.6A patent/CN106749231B/zh active Active
- 2016-11-08 WO PCT/CN2016/105012 patent/WO2018064852A1/zh not_active Ceased
- 2016-11-08 AU AU2016425880A patent/AU2016425880B2/en active Active
- 2016-11-08 PT PT169181856T patent/PT3421038T/pt unknown
- 2016-11-08 JP JP2019540476A patent/JP6862563B2/ja active Active
- 2016-11-08 ES ES16918185T patent/ES2784525T3/es active Active
- 2016-11-08 EP EP16918185.6A patent/EP3421038B1/en active Active
- 2016-11-08 PL PL16918185T patent/PL3421038T3/pl unknown
-
2017
- 2017-01-10 US US15/402,768 patent/US9938274B1/en active Active
-
2021
- 2021-01-15 JP JP2021005294A patent/JP7085032B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6862563B2 (ja) | 2021-04-21 |
| AU2016425880B2 (en) | 2020-09-17 |
| JP7085032B2 (ja) | 2022-06-15 |
| PT3421038T (pt) | 2020-04-22 |
| JP2021054871A (ja) | 2021-04-08 |
| CN106749231A (zh) | 2017-05-31 |
| US20180099962A1 (en) | 2018-04-12 |
| WO2018064852A1 (zh) | 2018-04-12 |
| ES2784525T3 (es) | 2020-09-28 |
| AU2016425880A1 (en) | 2019-05-30 |
| CN106749231B (zh) | 2019-03-01 |
| EP3421038A4 (en) | 2019-03-20 |
| US9938274B1 (en) | 2018-04-10 |
| EP3421038A1 (en) | 2019-01-02 |
| EP3421038B1 (en) | 2020-01-15 |
| JP2019534323A (ja) | 2019-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265260B (en) | pharmaceutical preparations | |
| IL265360A (en) | Pharmaceutical composition | |
| IL262654A (en) | Pharmacy preparation | |
| PL3421038T3 (pl) | Związek naftyrydyny, kompozycja farmaceutyczna i ich zastosowanie | |
| IL290114A (en) | Pharmaceutical preparations, their preparation and uses | |
| IL265349A (en) | Pharmaceutical composition | |
| IL252397A0 (en) | Pharmaceutical preparations, their preparation and uses | |
| HUE056175T2 (hu) | Gyógyászati készítmények, elõállításuk és alkalmazásaik | |
| IL252897A0 (en) | Indanyl compounds, pharmaceutical preparations and their medical uses | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| LT3229843T (lt) | Farmacinė kompozicija, jos paruošimo būdas ir naudojimas | |
| IL262929B1 (en) | Preparations for treatment, methods of their preparation and their uses | |
| GB201615917D0 (en) | Pharmaceutical composition | |
| PT3350150T (pt) | 1,1-difeniletilenos substituídos por alcenilfenoxilo, processos para a sua preparação e sua utilização | |
| IL257621B (en) | A catechol derivative and a pharmaceutical preparation that includes it | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| ZA201607353B (en) | Bicyclic derivatives and pharmaceutical composition including the same | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| IL265436B (en) | Pharmacy preparation | |
| PL3424500T3 (pl) | Kompozycja farmaceutyczna zawierająca famitynib | |
| GB201620519D0 (en) | Pharmaceutical composition | |
| AP2017009706A0 (en) | Pharmaceutical compound comprising 13 glycerides, formulation and application thereof | |
| IL265428A (en) | Pharmaceutical composition | |
| GB201620517D0 (en) | Pharmaceutical composition | |
| GB201620516D0 (en) | Pharmaceutical composition |